Disclosures for "A Real-world Study of Inebilizumab in Patients with Neuromyelitis Optica Spectrum Disorder: One-year Follow up Results"
-
The institution of Ms. Gui has received research support from Beijing Huikang Charity Foundation .
-
Dr. Bu has nothing to disclose.
-
Prof. Zhou has nothing to disclose.
-
Dr. Li has nothing to disclose.
-
Prof. Jin has nothing to disclose.
-
Dr. He has nothing to disclose.